Ergoresearch Ltd.  

(Public, CVE:ERG)   Watch this stock  
Find more results for ERG
+0.005 (3.13%)
May 2 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.17 - 0.17
52 week 0.15 - 0.55
Open 0.17
Vol / Avg. 67,300.00/84,176.00
Mkt cap 11.51M
P/E     -
Div/yield     -
EPS -0.10
Shares 74.15M
Beta 0.99
Inst. own     -
Feb 29, 2016
Q2 2016 Ergoresearch Ltd Earnings Release

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 0.01% -45.32%
Operating margin 0.89% -0.74%
EBITD margin - 5.60%
Return on average assets 0.01% -23.21%
Return on average equity 0.01% -27.59%
CDP Score - -


2101 Le Carrefour, Suite 200
+1-514-9313355 (Phone)
+1-514-9311299 (Fax)

Website links


Ergoresearch Ltd is a Canada-based investment portfolio Company. The Company is engaged in the field of healthcare. The Company designs and manufactures cutting edge technologies for the orthopedic industry. The Company holds a portfolio of patents in the bionics field, including the intellectual property used in the Power Knee. The Company designed and commercialized WebFit, the robotized custom-fit orthotics manufacturing software program and launched OdrA, a new category of orthotic that, with the action of its distraction-rotation action, revolutionizes the treatment of pain associated with knee osteoarthritis. The Company’s products include OdrA Worldwide Patented Distraction Orthotic, Custom Fit 3D Foot Orthotics, Mass Production of Custom Fit Orthotics, Podo-Barometric Sensor Pads & scanners, Motor-powered prosthesis Power Knee, 3D scanners and Numerical Control Machine Tools.

Officers and directors

Sylvain Boucher President, Chief Executive Officer, Director
Dominique Boudreau Vice President - Finance
Frederic Petit Vice President - Operations
Danielle Boucher Vice- President of Clinique du Pied Equilibre, Director
Catherine Chamouton Independent Director
Michel Pierron Independent Director
Francois Tellier Independent Director